Spyre Therapeutics, Inc. (SYRE): Capital Expenditures
$0
Year ended 2024-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $0 | n/a | 2025-02-27, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $38.0K | -93.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $573.0K | -86.6% | 2024-11-18, From 2021-01-01 |
| 2020-12-31 | $4.28M | +186.9% | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | $1.49M | +253.6% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $422.0K | -31.8% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $619.0K | +192.0% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $212.0K | +1.9% | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | $208.0K | +14.9% | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | $181.0K | n/a | 2017-03-23, From 2014-01-01 |